Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
SHC014748M in Relapsed or Refractory Peripheral T Cell Lymphoma
NCT04470141Phase 2Unknown
- Sponsor
- Nanjing Sanhome Pharmaceutical Co., Ltd.
- Start
- Aug 2020
- Primary completion
- May 2021
- Modality
- Small Molecules
01
Overview
A Phase 2 trial of shc014748m in peripheral T-cell lymphoma (PTCL), sponsored by Nanjing Sanhome Pharmaceutical Co., Ltd.. Status: unknown.
02
Drugs
shc014748m
03
Conditions
peripheral T-cell lymphoma (PTCL)
Beyond the preview
Go deeper on NCT04470141.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04470141.